Thomas E. Prisinzano

Author

Also Known As

Adhikary, Sweta, Jain, R., Prisinzano, T., Prisinzano, T.E., Prisinzano, Thomas E., T E Prisinzano, T PRISINZANO, T. E. Prisinzano, T. Prisinzano, T.E. Prisinzano

287

Publications

Citations

H-Index

118

Concepts

All Affiliations

University of Kansas University of Iowa National Institutes of Health National Institute on Drug Abuse University of Kentucky

About

Thomas E. Prisinzano is an author at University of Kansas specializing in pharmacology, medicine, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	60	3.1K
2	Natural Sciences	18	24	1.4K
3	Social Sciences	13	15	707
4	Health Sciences	12	12	555
5	Engineering	5	5	217

Thomas E. Prisinzano

121

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
An Opioid Agonist that Does Not Induce μ-Opioid Receptor—Arrestin Interactions or Receptor Internalization Chad E. Groer, Kevin Tidgewell, Robert A. Moyer, Molecular Pharmacology	2006	224
Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil Dorota Żółkowska, Raka Jain, Richard B. Rothman, Journal of Pharmacology and Experimental Therapeutics	2009	179
Gedunin, a Novel Hsp90 Inhibitor: Semisynthesis of Derivatives and Preliminary Structure−Activity Relationships Gary Brandt, Matthew Schmidt, Thomas E. Prisinzano, Journal of Medicinal Chemistry Molecular BiologyChemical BiologyPharmaceutical ChemistryMolecular PharmacologyMedicinal Chemistry	2008	162
Neoclerodane Diterpenes as a Novel Scaffold for μ Opioid Receptor Ligands Wayne W. Harding, Kevin Tidgewell, Nathan Byrd, Journal of Medicinal Chemistry Salvinorin ADrug TargetNeoclerodane DiterpenesPharmacotherapyMolecular Pharmacology	2005	151
Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors Lei Zhou, Kimberly M. Lovell, Kevin J. Frankowski, Journal of Biological Chemistry BiochemistryFunctional SelectivityMedicineNatural SciencesMechanism Of Action	2013	145
Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity Lisa K. Brents, Anna Gallus‐Zawada, Anna Radomińska‐Pandya, Biochemical Pharmacology Cannabis UsePartial Agonist ActivityBiochemistryFunctional SelectivityMedicine	2012	142
R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse Claus J. Løland, Maddalena Mereu, Oluyomi M. Okunola, Biological Psychiatry Psychostimulant AbuseSubstance AbusePsychoactive DrugPsychopathologyPsychiatry	2012	142
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum Matthew W. Johnson, Katherine A. MacLean, Chad J. Reissig, Drug and Alcohol Dependence Substance AbuseSalvinorin APsychoactive DrugPsychiatryAddiction	2010	134
Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects Katherine A. MacLean, Matthew W. Johnson, Chad J. Reissig, Psychopharmacology Salvinorin APsychoactive DrugMemory EffectsAddictionMedicine	2012	130
Reactive Oxygen and Targeted Antioxidant Administration in Endothelial Cell Mitochondria Yunxia O’Malley, Brian D. Fink, Nicolette C. Ross, Journal of Biological Chemistry Lipid PeroxidationChemical BiologyReactive Oxygen SpeciesRedox BiologyOxidative Stress	2006	121

Page 1